Molecular pathogenesis of oral submucous fibrosis--a collagen metabolic disorder
- PMID: 15946178
- DOI: 10.1111/j.1600-0714.2005.00325.x
Molecular pathogenesis of oral submucous fibrosis--a collagen metabolic disorder
Abstract
Oral submucous fibrosis (OSF) is a chronic debilitating disease and a premalignant condition of the oral cavity. It is characterized by a generalized submucosal fibrosis. The pathogenesis of the disease is not well established. Epidemiological evidences strongly indicate the association of the betel quid (BQ) habit and OSF. Various findings indicate the disease to be a consequence of disturbances in the homeostatic equilibrium between synthesis and degradation of extracellular matrix (ECM), wherein collagen forms a major component, thus can be considered as a collagen-metabolic disorder. Transforming growth factor-beta (TGF-beta) is a potent stimulator of production and deposition of the ECM. The objectives of this review are to highlight the molecular events involved in the overproduction of insoluble collagen and decreased degradation of collagen occurring via exposure to BQ and stimulation of the TGF-beta pathway, and elucidate the cell signaling that is involved in the etiopathogenesis of the disease process.
Similar articles
-
Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis.Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):646-53. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12101112
-
The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis.Clin Chim Acta. 2007 Aug;383(1-2):51-6. doi: 10.1016/j.cca.2007.04.014. Epub 2007 Apr 29. Clin Chim Acta. 2007. PMID: 17537414 Review.
-
Oral submucous fibrosis: review on aetiology and pathogenesis.Oral Oncol. 2006 Jul;42(6):561-8. doi: 10.1016/j.oraloncology.2005.08.005. Epub 2005 Nov 28. Oral Oncol. 2006. PMID: 16311067 Review.
-
The aetiology of oral submucous fibrosis: the stimulation of collagen synthesis by extracts of areca nut.Int J Oral Surg. 1981;10(Suppl 1):163-7. Int J Oral Surg. 1981. PMID: 6807873
-
Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.J Can Dent Assoc. 2008 Oct;74(8):735-40. J Can Dent Assoc. 2008. PMID: 18845065 Review.
Cited by
-
Novel Index Combining Pan-Immune-Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer.Int J Surg Oncol. 2024 Sep 30;2024:2124006. doi: 10.1155/2024/2124006. eCollection 2024. Int J Surg Oncol. 2024. PMID: 39376995 Free PMC article.
-
Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis.Clin Oral Investig. 2013 Jun;17(5):1375-82. doi: 10.1007/s00784-012-0824-z. Epub 2012 Aug 15. Clin Oral Investig. 2013. PMID: 22893038 Clinical Trial.
-
Autophagy mediates oral submucous fibrosis.Exp Ther Med. 2016 May;11(5):1859-1864. doi: 10.3892/etm.2016.3145. Epub 2016 Mar 11. Exp Ther Med. 2016. PMID: 27168817 Free PMC article.
-
A Case of Advanced Oral Submucous Fibrosis Management: Beyond Conventional Approach.Cureus. 2024 Jun 7;16(6):e61916. doi: 10.7759/cureus.61916. eCollection 2024 Jun. Cureus. 2024. PMID: 38978932 Free PMC article.
-
Noncoding RNAs in oral cancer.Wiley Interdiscip Rev RNA. 2023 May-Jun;14(3):e1754. doi: 10.1002/wrna.1754. Epub 2022 Aug 12. Wiley Interdiscip Rev RNA. 2023. PMID: 35959932 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources